Literature DB >> 18642670

A natural human IgM antibody that neutralizes botulinum neurotoxin in vivo.

Sharad P Adekar1, Fetweh H Al-Saleem, M D Elias, Katherine A Rybinski, Lance L Simpson, Scott K Dessain.   

Abstract

Affinity-matured human antibodies have demonstrated efficacy as countermeasures for exposure to botulinum neurotoxin (BoNT), which is the cause of the disease botulism category A select bioterror agent. Little is known, however, about the potential role of natural (un-mutated) antibodies in the protective immune response to BoNT. Here we describe the cloning of two human IgM antibodies that bind serotype A BoNT. Both are un-mutated IgM antibodies, consistent with an origin in naive B cells. One of the antibodies is able to fully neutralize a lethal dose of serotype A BoNT in vivo. These results suggest that the natural human antibody repertoire may play a role in protection from exposure to biological toxins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18642670     DOI: 10.1089/hyb.2007.0549

Source DB:  PubMed          Journal:  Hybridoma (Larchmt)        ISSN: 1554-0014


  2 in total

Review 1.  Monoclonal antibodies and toxins--a perspective on function and isotype.

Authors:  Siu-Kei Chow; Arturo Casadevall
Journal:  Toxins (Basel)       Date:  2012-06-11       Impact factor: 4.546

Review 2.  Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches.

Authors:  Christine Rasetti-Escargueil; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2019-09-12       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.